ALGER FUND
24F-2EL, 1995-12-28
Previous: AFFILIATED FUND INC, 24F-2NT, 1995-12-28
Next: AMELCO CORP, 10-K405, 1995-12-28




  The|                                             30 Montgomery Street
Alger|    Meeting the challenge of investing       Jersey City, New Jersey 07302
 Fund|                                             (201) 547-3600
                                                   (800) 992-3863




                                                              December 27, 1995

Securities and Exchange Commission
450 Fifth St., N.W.
Washington, DC 20549

RE:      FORM 24F-2 FOR THE ALGER FUND
         SECURITIES ACT FILE NO. 33-4959

Dear Sir or Madam:

         On behalf of The Alger Fund (the "Fund") we hereby  transmit for filing
pursuant to Rule 24f-2 (the "Rule") under the Investment Company Act of 1940, as
amended,  Form 24F-2 for the Fund's  fiscal  year ended  October  31,  1995  and
the opinion of counsel specified in paragraph (b)(1) of the Rule.

         The required fee has been wired to the SEC account at Mellon Bank.

                                    Very truly yours,



                                    Nanci K. Staple
                                    Secretary

NKS/bd
Enclosure

<PAGE>

[letterhead of Sullivan & Worcester]
                                                            Boston
                                                            December 22, 1995

The Trustees of The Alger Fund
75 Maiden Lane
New York, New York  10038

                  Re: The Alger Fund:  Notice Pursuant to Rule 24f-2

Ladies and Gentlemen:

         You have requested our opinion as to certain  matters of  Massachusetts
law in connection  with the Notice  pursuant to Rule 24f-2 under the  Investment
Company  Act of 1940,  as amended  (the  "Notice"),  for the  fiscal  year ended
October  31,  1995,  being filed by The Alger  Fund,  a trust with  transferable
shares  (the  "Trust"),  established  under  Massachusetts  law  pursuant  to  a
Declaration  of Trust  dated  March 20,  1986,  as amended by  amendments  filed
October 17, 1986 (4 separate  amendments),  March 24, 1992, February 25, 1993 (2
separate  amendments),  August 18, 1993,  March 30, 1995 and May 26, 1995 (as so
amended, the "Declaration").

         We acted as counsel to the Trust in  connection  with the execution and
delivery of the  Declaration,  and for purposes of this opinion we have reviewed
the actions  taken by the  Trustees  of the Trust to  organize  the Trust and to
authorize  the  issuance  and sale of shares  of  beneficial  interest,  one mil
($.001) par value,  of the several  series  authorized by the  Declaration  (the
"Shares"). In this connection,  we have participated in the drafting of, and are
familiar  with, the  Declaration  and the Bylaws of the Trust,  the Notice,  the
forms of the  Prospectus and the Statement of Additional  Information  presently
included in the Trust's  Registration  Statement on Form N-1A,  certificates  of
public  officials  and of  Trustees  and  officers of the Trust as to matters of
fact,  and  such  other  documents  and  instruments,   certified  or  otherwise
identified to our  satisfaction,  and such questions of law and fact, as we have
considered  necessary or  appropriate  for  purposes of the  opinions  expressed
herein.  We  have  assumed  the  genuineness  of  the  signatures  on,  and  the
authenticity  of,  all  documents  furnished  to us, and the  conformity  to the
originals of documents submitted to us as certified copies,  which facts we have
not independently verified.

         Based upon and subject to the foregoing,  we hereby advise you that, in
our opinion, under the laws of the Commonwealth of Massachusetts:

<PAGE>
The Trustees of          
  The Alger Fund                       -2-                     December 22, 1995

     1.   The Trust is validly existing as a trust with  transferable  shares of
          the type commonly called a Massachusetts business trust.

     2.   The Trust is  authorized to issue an unlimited  number of Shares;  the
          Shares  issued by the Trust  during the fiscal year ended  October 31,
          1995 (the "Issued  Shares")  have been duly and validly  authorized by
          all  requisite  action of the Trustees of the Trust,  and no action of
          the shareholders of the Trust is required in such connection.

     3.   The Issued Shares have been validly and legally issued, and all of the
          Issued  Shares which remain  outstanding  at the date hereof are fully
          paid and nonassessable by the Trust.

         With  respect to the opinion  stated in  paragraph 3 above,  we wish to
point out that the shareholders of a Massachusetts business trust may under some
circumstances  be subject to  assessment at the instance of creditors to pay the
obligations of such trust in the event that its assets are  insufficient for the
purpose.

         This  letter  expresses  our  opinions  as to  the  provisions  of  the
Declaration  and the  laws of The  Commonwealth  of  Massachusetts  applying  to
business trusts generally,  but does not extend to the Massachusetts  Securities
Act, or to federal securities or other laws.

         We hereby consent to the filing of this opinion with the Securities and
Exchange Commission, together with the Notice. In giving such consent, we do not
thereby  concede  that we come within the category of persons  whose  consent is
required under Section 7 of the Securities Act of 1933, as amended.

                                    Very truly yours,

                                    /s/ Sullivan & Worcester, LLP   
                                    SULLIVAN & WORCESTER
                                    (A REGISTERED LIMITED LIABILITY PARTNERSHIP)

<PAGE>

                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 24F-2
                        ANNUAL NOTICE OF SECURITIES SOLD
                             PURSUANT TO RULE 24F-2

- --------------------------------------------------------------------------------
1.   Name and address of issuer:
     
     The Alger Fund
     75 Maiden Lane
     New York, NY 10038
- --------------------------------------------------------------------------------
2.   Name of each series or class of funds for which this notice is filed:

     Alger Money Market Portfolio
     Alger Small Capitalization Portfolio
     Alger Growth Portfolio
     Alger Balanced Portfolio
     Alger MidCap Growth Portfolio
     Alger Capital Appreciation Portfolio
- --------------------------------------------------------------------------------
3.   Investment Company Act File Number:     811-6880
     
     Securities Act File Number:   33-4959
- --------------------------------------------------------------------------------
4.   Last day of fiscal year for which this notice is filed:

     October 31
- --------------------------------------------------------------------------------
5.   Check box if this  notice is being filed more than 180 days after the close
     of the issuer's fiscal year for purposes of reporting securities sold after
     the close of the fiscal year but before  termination  of the issuer's 24f-2
     declaration:
                                                                            [ ]
- --------------------------------------------------------------------------------
6.   Date of  termination of issuer's  declaration  under rule  24f-2(a)(1),  if
     applicable (see instruction A.6):

- --------------------------------------------------------------------------------
7.   Number and amount of  securities of the same class or series which had been
     registered  under the Securities  Act of 1933,  other than pursuant to rule
     24f-2 in a prior fiscal year, but which remained unsold at the beginning of
     the fiscal year:

     None 
- --------------------------------------------------------------------------------
8.   Number and amount of  securities  registered  during the fiscal  year other
     than pursuant to rule 24f-2:

     None
- --------------------------------------------------------------------------------
9.   Number and aggregate sale price of securities sold during the fiscal year:

     425,634,901
     $855,152,847
- --------------------------------------------------------------------------------

<PAGE>

- --------------------------------------------------------------------------------
10.  Number and aggregate  sale price of securities  sold during the fiscal year
     in reliance upon registration pursuant to rule 24f-2:

     425,634,901
     $855,152,847
- --------------------------------------------------------------------------------
11.  Number and  aggregrate  sale price of  securities  issued during the fiscal
     year in connection  with dividend  reinvestment  plans,  if applicable (see
     Instruction B.7):

     N/A
- --------------------------------------------------------------------------------
12.  Calculation of registration fee:

     (i)    Aggregate sale price of securities
            sold during the fiscal year in reliance
            on rule 24f-2 (from Item 10):              $       855,152,847
                                                       -------------------
     (ii)   Aggregate price of shares issued in
            connection with dividend reinvestment
            plans (from Item 11, if applicable):       +           --
                                                       -------------------
     (iii)  Aggregate price of shares redeemed
            or repurchased during
            the fiscal year (if applicable):           -      $709,148,356
                                                       -------------------
     (iv)   Aggregate price of shares redeemed
            or repurchased and previously applied 
            as a reduction to filing fees pursuant
            to rule 24e-2 (if applicable):             +           --
                                                       -------------------
     (v)    Net aggregate  price of securities 
            sold and issued during the fiscal
            year in reliance on rule 24f-2 [line (i), 
            plus line (ii),  less line
            (iii), plus line (iv)] (if applicable):           $146,004,491
                                                       -------------------
     (vi)   Multiplier prescribed by Section 6(b) 
            of the Securities Act of 1933 or other 
            applicable law or regulation
            (see Instruction C.6):                     x      1/29th of 1%
                                                       -------------------
     (vii)  Fee due [line (i) or line (v) multiplied 
            by line (vi)]:                                      $50,346.38
                                                       ===================

Instruction:  Issuers should complete lines (ii),  (iii),  (iv), and (v) only if
              the form is being  filed  within 60 days  after  the close of  the
              issuer's fiscal year. See Instruction C.3.
- --------------------------------------------------------------------------------
13.  Check box if fees are being remitted to the Commission's lockbox depository
     as described in section 3a of the Commission's  Rules of Informal and Other
     Procedures (17 CFR 202.3a).

                                                                          [xxx]
     Date of mailing or wire transfer of filing fees to the Commission's lockbox
     depository:

     December 28, 1995
- --------------------------------------------------------------------------------
                                   SIGNATURES

     This report has been signed below by the following persons on behalf of the
     issuer and in the capacities and on the dates indicated.

     By (Signature and Title)*      /s/ Nanci K. Staple
                                    -----------------------------------
                                    Nanci K. Staple, Secretary
                                    -----------------------------------

     Date      12/20/95
          ------------------

  *Please print the name and title of the signing officer below the signature.
- --------------------------------------------------------------------------------


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission